Adaptimmune Therapeutics plc American (ADAP) Revenue by Year
Adaptimmune Therapeutics plc American generated $178.0M in revenue in fiscal year 2024. This represents an increase of 195.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to $65.1M in revenue. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters Adaptimmune Therapeutics plc American has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ADAP Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.1M | $178.0M+195.3% | $60.3M+122.0% | $27.1M+341.5% | $6.1M+55.4% | $4.0M+252.8% | $1.1M-98.1% | $59.5M+57.3% | $37.8M+166.5% | $14.2M+43.8% | $9.9M+1096.5% | $825K | N/A |
TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
ADAP Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Adaptimmune Therapeutics plc American financials
Frequently Asked Questions
What was Adaptimmune Therapeutics plc American's revenue in fiscal year 2024?
Adaptimmune Therapeutics plc American generated $178.0M in revenue in fiscal year 2024.
How fast is Adaptimmune Therapeutics plc American's revenue growing?
Adaptimmune Therapeutics plc American (ADAP) revenue rose by 195.3% year over year, from $60.3M to $178.0M in fiscal year 2024.
What is Adaptimmune Therapeutics plc American's revenue over the last twelve months?
Adaptimmune Therapeutics plc American (ADAP) reported $65.1M in revenue over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
What was Adaptimmune Therapeutics plc American's revenue in the most recent quarter?
Adaptimmune Therapeutics plc American (ADAP) reported $13.7M in revenue in Q2 2025. This represents a decrease of 89.3% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Adaptimmune Therapeutics plc American (ADAP) reported on that line in every period on record.